Replies to post #24345 on Biotech Values

[DewDiligence]

Re: INGN

>Maybe this will help<

Actually, the PR you cited from June raises even more questions:

>>
To date,12 patients (66.7 percent) had objective responses or tumor reduction greater than 50%. Historically the expected objective response rate in these patients is between 20 and 30 percent.
<<

In the June PR the response rate was reported as 66.7% (12/18), but in today’s PR the RR is reported as 62% (with no patient count).

Moreover, in the June PR it said that the historical response rate on second-line chemo is 20-30%, but in today’s PR it says that the historical RR is 5-25%.

I don’t get it.